Financial Year |
March 31 2023 |
Monetary Funds |
641,427,705.96 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
24,154,528.36 |
Advances to Suppliers |
4,602,763.27 |
Other Receivables |
31,971,465.06 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
180,230,096.15 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
48,736,099.28 |
Total Current Assets |
931,122,658.08 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
1,093,458.00 |
Investment Properties |
-- |
Fixed Assetes |
113,037,160.43 |
Under-construction Projects |
6,090,508.87 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
15,382,235.27 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
18,686,730.52 |
Deferred Income Tax Assets |
41,177,559.41 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
271,138,954.75 |
Total Assets |
1,202,261,612.83 |
Short-Term Loans |
105,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
14,678,981.36 |
Accounts Payable |
40,202,608.26 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
21,371,084.29 |
Taxes Payable |
3,198,098.79 |
Interest Payable |
80,745.00 |
Dividend Payable |
-- |
Other payables |
21,444,586.38 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
29,226,581.82 |
Other Current Liabilities |
459,373.08 |
Sub-Total of Current Liabilities |
243,385,821.69 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
130,776.92 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
55,729,033.44 |
Total Liabilities |
299,114,855.13 |
Paid-In Capital(Or Share Stock) |
212,081,352.00 |
Capital Surplus |
633,006,249.23 |
Surplus Reserve |
41,203,531.75 |
LESS:Treasury Stock |
4,999,392.61 |
Undistributed Profits |
20,410,526.63 |
Minority Stockholder's Interest |
1,444,490.70 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
901,702,267.00 |
Owner's Equity(Stockholder's Equity) |
903,146,757.70 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,202,261,612.83 |